Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Olson Eric R
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc.
Chief Scientific Officer
Avg. Two Year Performance
No Purchase Track Record
36%
Avg. Sale Return
17%
Compound
Holdings:
6.66K
shares
Last Three Months: 29-Jan-24 -- 28-Apr-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Other
Other
Two Year Chart
29-Apr-22 -- 28-Apr-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions